Enzo Biochem (ENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENZ | AMGN | GILD | BIIB | CELG |
| Company | Enzo Biochem | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.1600 | 269.93 | 68.27 | 198.73 | 108.01 |
| High | 1.1999 | 270.93 | 68.46 | 199.53 | 108.59 |
| Low | 1.1600 | 264.35 | 67.70 | 196.40 | 107.27 |
| Last | 1.1600 | 265.51 | 67.75 | 196.80 | 108.24 |
| Change | -0.0100 | -1.77 | -0.32 | -1.38 | +0.11 |
| % Change | -0.85% | -0.66% | -0.47% | -0.70% | +0.10% |
| Volume | 117,200 | 1,740,100 | 7,717,800 | 1,159,200 | 191,230,496 |
| 20-Day Average Volume | 89,905 | 2,348,660 | 6,525,295 | 1,116,865 | 16,188,930 |
| Previous Close | 1.1700 | 267.28 | 68.07 | 198.18 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 1.2325 | 274.13 | 71.23 | 210.27 | 108.17 |
| 20-Day Raw Stochastic | 0.00% | 4.81% | 1.95% | 1.58% | 63.25% |
| 20-Day Relative Strength | 36.61% | 38.68% | 31.69% | 30.57% | 64.69% |
| Weighted Alpha | -47.63 | +5.78 | -22.75 | -35.90 | +46.30 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 72% Sell | 8% Sell | 40% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.33% since 04/08/24 | -1.37% since 04/08/24 | -2.41% since 04/08/24 | -3.98% since 04/08/24 | -1.97% since 11/13/19 |
| Low | 1.1600 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 196.40 on 04/15/24 | 107.27 on 11/20/19 |
| High | 1.2400 on 04/11/24 | 273.00 on 04/11/24 | 69.95 on 04/09/24 | 209.06 on 04/09/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -4.13% since 03/15/24 | -1.25% since 03/15/24 | -8.06% since 03/15/24 | -10.26% since 03/15/24 | +5.14% since 10/18/19 |
| Low | 1.1600 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 196.40 on 04/15/24 | 102.40 on 10/21/19 |
| High | 1.3000 on 04/05/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 221.74 on 03/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -16.55% since 01/12/24 | -13.38% since 01/12/24 | -21.57% since 01/12/24 | -20.68% since 01/12/24 | +13.63% since 08/20/19 |
| Low | 1.1600 on 04/15/24 | 264.35 on 04/15/24 | 67.62 on 04/12/24 | 196.40 on 04/15/24 | 93.41 on 08/23/19 |
| High | 1.4360 on 01/18/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 252.17 on 01/22/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -18.88% since 10/13/23 | -6.54% since 10/13/23 | -12.75% since 10/13/23 | -24.96% since 10/13/23 | +14.14% since 05/20/19 |
| Low | 1.1600 on 04/15/24 | 249.70 on 10/31/23 | 67.62 on 04/12/24 | 196.40 on 04/15/24 | 89.08 on 07/23/19 |
| High | 1.5000 on 01/03/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 269.43 on 10/17/23 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 59,934 | 143,240,432 | 84,752,392 | 28,807,640 | 77,035,920 |
| Shares Outstanding, K | 51,226 | 535,919 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 31,060,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | 20,290,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 8,550,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | -3,060,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | 0.75 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 03/13/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 03/18/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | 0.063 on 06/29/95 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.33 | 10.13 | 13.45 | 10.99 |